+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Third-party Medical Testing Services Market by Test Type (Clinical Chemistry, Hematology, Histopathology), End User (Academic and Research Institutes, Diagnostic Centers, Hospitals), Technology, Application, Sample Type - Global Forecast 2025-2030- Product Image
Third-party Medical Testing Services Market by Test Type (Clinical Chemistry, Hematology, Histopathology), End User (Academic and Research Institutes, Diagnostic Centers, Hospitals), Technology, Application, Sample Type - Global Forecast 2025-2030- Product Image
Sale

Third-party Medical Testing Services Market by Test Type (Clinical Chemistry, Hematology, Histopathology), End User (Academic and Research Institutes, Diagnostic Centers, Hospitals), Technology, Application, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6080033
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Third-party medical testing services are playing a central role in healthcare transformation, offering expanded diagnostic capabilities, operational efficiencies, and pivotal support for clinical decision-making in a rapidly evolving, technology-driven landscape.

Market Snapshot: Third-Party Medical Testing Services

The third-party medical testing services market is experiencing accelerated growth, driven by rapid healthcare innovation, increasing patient expectations, and a shift toward value-based care models. Recent years have seen significant advancements in diagnostic methodologies and specialized assays, elevating the strategic importance of outsourcing laboratory services. The competitive environment is shaped by evolving partnerships among hospitals, research institutes, and pharmaceutical companies seeking improved outcomes, cost control, and technology-enabled service delivery. Demand for robust automation platforms, integration with advanced analytical tools, and agile collaboration now underpins the sector’s forward momentum, as industry participants respond to operational pressures and shifting regulatory frameworks.

Scope & Segmentation

  • Test Types: Clinical chemistry, hematology, histopathology, immunology, microbiology, molecular diagnostics, including next-generation sequencing and PCR.
  • End Users: Academic and research institutes, diagnostic centers, private hospitals, public hospitals, pharmaceutical and biotech companies.
  • Technologies: Immunoassays, mass spectrometry, microscopy, PCR (digital, quantitative), and sequencing platforms.
  • Applications: Cardiology, genetic testing, infectious diseases, neurology, oncology, including liquid and tissue biopsy approaches.
  • Sample Types: Blood (plasma, serum, whole blood), saliva, tissue, and urine.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, and others), Asia-Pacific (China, India, Japan, Australia, and additional markets).
  • Companies Analyzed: Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Sonic Healthcare Limited, Synlab AG, Unilabs Holding SA, Charles River Laboratories International, Inc., Cerba HealthCare S.A., Bio-Reference Laboratories, Inc., Fulgent Genetics, Inc.

Key Takeaways

  • The integration of artificial intelligence and machine learning within diagnostic workflows enhances test accuracy, predictive insights, and operational agility.
  • Collaborative business models, such as sharing risk arrangements and bundled testing, are strengthening provider-payer alignment and accelerating the adoption of novel assays in the healthcare continuum.
  • Decentralized approaches, including hybrid models that combine centralized facilities and point-of-care platforms, enable responsiveness across diverse outpatient and community settings.
  • Operational resilience hinges on flexible procurement strategies, workflow optimization, and supply chain transparency to absorb cost fluctuations caused by tariffs or policy changes.
  • Regional nuances shape growth strategies as laboratories tailor offerings to varying regulatory, infrastructural, and clinical demands across the Americas, EMEA, and APAC geographies.

Tariff Impact: U.S. 2025 Measures on Medical Testing

The introduction of U.S. tariffs in 2025, focusing on imported diagnostic reagents and instrumentation components, has increased input costs for laboratories. Providers are adapting by consolidating test volumes, exploring domestic partnerships, and enhancing procurement agility to maintain service quality and margin stability. As laboratories recalibrate pricing structures and supply sources, their ability to mitigate financial and operational risks is increasingly under scrutiny.

Methodology & Data Sources

This analysis is grounded in a multilayered research approach, combining secondary sources—government data, regulatory filings, industry journals—with primary insights from interviews with laboratory executives and subject matter experts. Quantitative survey data was validated through triangulation, while analytical frameworks such as SWOT and scenario planning supported robust findings.

Why This Report Matters

  • Guides strategic investments by highlighting emerging technologies, collaborative models, and nuanced market segmentation.
  • Provides actionable intelligence for navigating regulatory shifts and optimizing operational models in both established and emerging regions.
  • Enables senior decision-makers to benchmark against leading laboratory strategies and identify high-impact opportunities in third-party medical testing services.

Conclusion

As healthcare priorities evolve, the convergence of technological innovation and partnership-driven models is redefining the third-party medical testing landscape. Providers who embrace operational agility and strategic alliances will secure durable competitive advantages in this dynamic sector.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing demand for at-home sample collection kits integrating digital health tracking and teleconsultation
5.2. Increasing partnerships between diagnostic labs and telemedicine providers to expand testing access
5.3. Advancement of AI-driven diagnostic platforms for rapid interpretation of complex biomarker profiles
5.4. Rising use of liquid biopsy testing for early cancer detection and monitoring treatment response
5.5. Expansion of direct-to-consumer microbiome analysis services supporting personalized nutrition advice
5.6. Surge in multiomic testing solutions combining genomics proteomics and metabolomics for precision medicine
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Third-party Medical Testing Services Market, by Test Type
8.1. Introduction
8.2. Clinical Chemistry
8.2.1. Automated Chemistry Analyzers
8.2.2. Point of Care Chemistry Testing
8.3. Hematology
8.4. Histopathology
8.5. Immunology
8.6. Microbiology
8.7. Molecular Diagnostics
8.7.1. Next Generation Sequencing
8.7.2. PCR
9. Third-party Medical Testing Services Market, by End User
9.1. Introduction
9.2. Academic and Research Institutes
9.3. Diagnostic Centers
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
9.5. Pharmaceutical and Biotech Companies
10. Third-party Medical Testing Services Market, by Technology
10.1. Introduction
10.2. Immunoassays
10.3. Mass Spectrometry
10.4. Microscopy
10.5. PCR
10.5.1. Digital PCR
10.5.2. Quantitative PCR
10.6. Sequencing
11. Third-party Medical Testing Services Market, by Application
11.1. Introduction
11.2. Cardiology
11.3. Genetic Testing
11.4. Infectious Diseases
11.5. Neurology
11.6. Oncology
11.6.1. Liquid Biopsy
11.6.2. Tissue Biopsy
12. Third-party Medical Testing Services Market, by Sample Type
12.1. Introduction
12.2. Blood
12.2.1. Plasma
12.2.2. Serum
12.2.3. Whole Blood
12.3. Saliva
12.4. Tissue
12.5. Urine
13. Americas Third-party Medical Testing Services Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Third-party Medical Testing Services Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Third-party Medical Testing Services Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Laboratory Corporation of America Holdings
16.3.2. Quest Diagnostics Incorporated
16.3.3. Eurofins Scientific SE
16.3.4. Sonic Healthcare Limited
16.3.5. Synlab AG
16.3.6. Unilabs Holding SA
16.3.7. Charles River Laboratories International, Inc.
16.3.8. Cerba HealthCare S.A.
16.3.9. Bio-Reference Laboratories, Inc.
16.3.10. Fulgent Genetics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. THIRD-PARTY MEDICAL TESTING SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. THIRD-PARTY MEDICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. THIRD-PARTY MEDICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. THIRD-PARTY MEDICAL TESTING SERVICES MARKET: RESEARCHAI
FIGURE 26. THIRD-PARTY MEDICAL TESTING SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 27. THIRD-PARTY MEDICAL TESTING SERVICES MARKET: RESEARCHCONTACTS
FIGURE 28. THIRD-PARTY MEDICAL TESTING SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. THIRD-PARTY MEDICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY AUTOMATED CHEMISTRY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY AUTOMATED CHEMISTRY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY POINT OF CARE CHEMISTRY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY POINT OF CARE CHEMISTRY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY DIGITAL PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 153. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 154. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 155. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 156. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 157. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 158. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 159. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 162. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 163. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 166. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 167. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 170. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 171. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 174. CANADA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 175. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 178. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 179. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 188. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 189. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 192. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 193. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 196. MEXICO THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 287. GERMANY THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 288. GERMANY THIRD-PARTY MEDICAL TESTING SERVICES MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 289. GERMANY THIRD-PARTY MEDICAL TESTING SERVICES MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Third-party Medical Testing Services market report include:
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Eurofins Scientific SE
  • Sonic Healthcare Limited
  • Synlab AG
  • Unilabs Holding SA
  • Charles River Laboratories International, Inc.
  • Cerba HealthCare S.A.
  • Bio-Reference Laboratories, Inc.
  • Fulgent Genetics, Inc.

Related Topics

Related Reports

Cellular Health Testing - Global Strategic Business Report - Product Image

Cellular Health Testing - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Routine Health Screening Market Report 2025 - Product Image

Routine Health Screening Market Report 2025

  • Report
  • 175 Pages
  • Global
From
2025 Global Forecast for Cellular Health Screening/Health Testing Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Cellular Health Screening/Health Testing Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Breast Cancer Liquid Biopsy Testing Devices Market by Technology, Application, End User, Test Type, Sample Type, Indication, Distribution Channel - Global Forecast 2025-2030 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market by Technology, Application, End User, Test Type, Sample Type, Indication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Cervical Cancer Diagnostic Market by Product Type (Instruments, Kits & Reagents), Test Type (Cytology, Hpv Dna Testing, Visual Inspection), Technology, End User, Sample Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Cervical Cancer Diagnostic Market by Product Type (Instruments, Kits & Reagents), Test Type (Cytology, Hpv Dna Testing, Visual Inspection), Technology, End User, Sample Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.